Chemoinformaics analysis of 3-Methyl-2-pentanol
| Molecular Weight | 102.177 | nRot | 2 |
| Heavy Atom Molecular Weight | 88.065 | nRig | 1 |
| Exact Molecular Weight | 102.104 | nRing | 0 |
| Solubility: LogS | -5.438 | nHRing | 0 |
| Solubility: LogP | 5.321 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 21 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 7 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 20.1571 |
| nHD | 1 | BPOL | 14.0449 |
| QED | 0.375 |
| Synth | 2.041 |
| Natural Product Likeliness | 0.325 |
| NR-PPAR-gamma | 0.045 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.51 |
| MDCK | 0.0000116 |
| BBB | 0.847 |
| PPB | 0.968927 |
| VDSS | 2.975 |
| FU | 0.0108325 |
| CYP1A2-inh | 0.966 |
| CYP1A2-sub | 0.337 |
| CYP2c19-inh | 0.758 |
| CYP2c19-sub | 0.766 |
| CYP2c9-inh | 0.484 |
| CYP2c9-sub | 0.933 |
| CYP2d6-inh | 0.557 |
| CYP2d6-sub | 0.087 |
| CYP3a4-inh | 0.36 |
| CYP3a4-sub | 0.103 |
| CL | 3.298 |
| T12 | 0.207 |
| hERG | 0.072 |
| Ames | 0.015 |
| ROA | 0.111 |
| SkinSen | 0.931 |
| Carcinogencity | 0.256 |
| EI | 0.988 |
| Respiratory | 0.897 |
| NR-Aromatase | 0.029 |
| Antiviral | No |
| Prediction | 0.956165 |